Business
Microbix Presents Reference-Material Innovations at EUROGIN
QUANTDx Samples with "Normalized" Viral Loads for Validating HPV Assays MISSISSAUGA, ON / A...
About this update from Microbix Biosystems Inc.
[{"type":"text","content":"Microbix Presents Reference-Material Innovations at EUROGINQUANTDx Samples with \"Normalized\" Viral Loads for Validating HPV Assays MISSISSAUGA, ON / ACCESS Newswire / March 17, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF)(Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of novel QUANTDx™ reference materials designed to emulate real-life human papillomavirus (\"HPV\") patient-samples and thereby better support the validation of molecular (e.g., \"PCR\") tests for infection. Microbix is presenting at EUROGIN, an international conference and exhibition focused upon innovations in HPV research and global cancer solutions taking place in Vienna, Austria from March 18 to 21, 2026.The QUANTDx product line comprises accurately-quantified and fully-traceable reference materials that enable assay developers to establish key analytical performance metrics - such as LoD (limit of detection), Sensitivity (positive accuracy), and Specificity (negative accuracy) - that are essential for regulatory submissions and validation. QUANTDx includes over 80 such reference materials that cover six of the most commonly tested disease panels, namely fungal, gastrointestinal, HPV, meningitis, respiratory, and sexually-transmitted infections. The QUANTDx line addresses critical needs within the infectious disease diagnostics industry for high-quality, reliable, and standardized reference materials.Microbix's EUROGIN Poster presentation takes QUANTDx a further leap forward by \"normalizing\" the count of HPV viral genomes relative to the number of human cells present. Normalization of viral count to the number of human cells present is critical to understanding sample adequacy and, in turn, interpreting whether HPV infections are latent (lower risk), medium, or in active replication (higher risk). The Poster is titled \"Novel HPV Reference Materials Representing Normalized Viral Load for Use in Assay Validation.\" Microbix is grateful to its external collaborators and co-authors Katherine Lutz and Larry Vaughn of BD Life Sciences, and thanks staff authors Pavel Zhelev, Sydney Rivers, Amer Alagic, Jieran Li, & Connor Randall. After being presented at ESCMID, the Poster will be made available at https://microbix.comWhile standard HPV reference materials are widely available,...